Eruzun, H. (2026). Sclerosing cholangitis associated with dabrafenib–trametinib therapy: BRAF/MEK inhibitors should be considered. Journal of Gastrointestinal and Liver Diseases, 35(1), 136–137. https://doi.org/10.15403/jgld-6698